MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2

Figure 1

YAP/TAZ is activated in COAD. (a, b) Representative examples of immunostaining images and column diagrams for YAP1 and TAZ in the 21 COAD tumors and corresponding noncancerous tissues. (c, d) Western blotting analysis of YAP/TAZ protein expression in the paired COAD tissues. (e) mRNA expression levels of YAP1 and TAZ in COAD. (f) Bioinformatic analysis in TCGA for LATS1 and LATS2 expressions. (g) Quantitative PCR amplification verification of LATS1 and LATS2 expression in the collected 21 paired COAD tissues.

(a)

(b)

(c)

(d)

(e)

(f)

(g)